Energy Secretary Jennifer Granholm visited ORNL on Nov. 22 for a two-hour tour, meeting top scientists and engineers as they highlighted projects and world-leading capabilities that address some of the country’s most complex research and technical challenges.
Research teams from the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2021 R&D 100 Awards, plus special recognition for a COVID-19-related project.
ORNL's Larry Baylor and Andrew Lupini have been elected fellows of the American Physical Society.
Diego Del-Castillo-Negrete, a distinguished staff member in the Fusion Energy Division, was cited for Outstanding Technical Achievement – National Laboratory. He will be recognized during the GMiS annual conference, which will be held virtually Oct. 11-22. The HENAAC awards program is in its 33rd year.
A 25-year career with the U.S. Navy, commanding combat missions overseas, brought Tom Kollie back to where he came from — ready to serve his country in a new way.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
Joseph Pickel has been elected a 2021 fellow of the American Chemical Society, or ACS. Pickel supports the Fusion and Fission Energy and Sciences Directorate as environment, safety and health
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
Kathy McCarthy, associate laboratory director for Fusion and Fission Energy and Science at the Department of Energy’s Oak Ridge National Laboratory, has been elected fellow of the American Nuclear Society for her nationally and internationally recognized leadership in nuclear energy and fusion.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.